Zhen Teng Liu
Director Ejecutivo en SHANDONG LUOXIN PHARMACY GROUP CO LTD .
Fortuna: 3 M $ al 30/04/2024
Perfil
Zhen Teng Liu is currently the Chairman & General Manager at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
and Luoxin Pharmaceuticals Group Stock Co., Ltd.
He started his current positions in 2013 and 2020 respectively.
In terms of education, Mr. Liu holds an MBA from The University of New South Wales and an undergraduate degree from Macquarie University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/07/2023 | 4 689 648 ( 0.96% ) | 3 M $ | 30/04/2024 |
Cargos activos de Zhen Teng Liu
| Empresas | Cargo | Inicio |
|---|---|---|
| SHANDONG LUOXIN PHARMACY GROUP CO LTD | Director Ejecutivo | 31/01/2023 |
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Director Ejecutivo | 23/04/2023 |
Formación de Zhen Teng Liu.
| Macquarie University | Undergraduate Degree |
| The University of New South Wales | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on May 05, 1998 and is headquartered in Linyi, China. | Health Technology |
- Bolsa de valores
- Insiders
- Zhen Teng Liu